Photobiomodulation (PBM) can benefit neurodegenerative diseases; including Alzheimer's Disease, Parkinson's Disease, dementia, traumatic brain injury (TBI), stroke, spinal cord injury, and degenerative central nervous system disease. PBM has been shown to significantly improve cognition in mild to moderately severe dementia and possible Alzheimer's Disease cases as well as TBI patients even years after injury. PBM has also been shown to improve neuronal function in patients with Parkinson's Disease. In addition, PBM has been shown in rodent studies to reverse memory degradation.
Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report.
Saltmarche AE1, Naeser MA2,3, Ho KF4, Hamblin MR5,6, Lim L7.
Low-power laser irradiation inhibiting Abeta25-35-induced PC12 cell apoptosis via PKC activation.
Zhang L1, Xing D, Zhu D, Chen Q.
Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy.
Trimmer PA1, Schwartz KM, Borland MK, De Taboada L, Streeter J, Oron U.
Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports.
Naeser MA1, Saltmarche A, Krengel MH, Hamblin MR, Knight JA.
Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).
Lampl Y1, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B, Borenstein P, Andersson B, Perez J, Caparo C, Ilic S, Oron U.
Emotional responses and memory performance of middle-aged CD1 mice in a 3D maze: effects of low infrared light.
Michalikova S1, Ennaceur A, van Rensburg R, Chazot PL.